GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hyphens Pharma International Ltd (SGX:1J5) » Definitions » Current Ratio

Hyphens Pharma International (SGX:1J5) Current Ratio : 2.20 (As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Hyphens Pharma International Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Hyphens Pharma International's current ratio for the quarter that ended in Jun. 2023 was 2.20.

Hyphens Pharma International has a current ratio of 2.20. It generally indicates good short-term financial strength.

The historical rank and industry rank for Hyphens Pharma International's Current Ratio or its related term are showing as below:

SGX:1J5' s Current Ratio Range Over the Past 10 Years
Min: 1.28   Med: 1.93   Max: 2.27
Current: 2.2

During the past 8 years, Hyphens Pharma International's highest Current Ratio was 2.27. The lowest was 1.28. And the median was 1.93.

SGX:1J5's Current Ratio is ranked better than
69.72% of 677 companies
in the Healthcare Providers & Services industry
Industry Median: 1.37 vs SGX:1J5: 2.20

Hyphens Pharma International Current Ratio Historical Data

The historical data trend for Hyphens Pharma International's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyphens Pharma International Current Ratio Chart

Hyphens Pharma International Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Current Ratio
Get a 7-Day Free Trial 1.80 2.01 2.27 1.74 2.24

Hyphens Pharma International Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.18 1.74 2.10 2.24 2.20

Competitive Comparison of Hyphens Pharma International's Current Ratio

For the Pharmaceutical Retailers subindustry, Hyphens Pharma International's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hyphens Pharma International's Current Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Hyphens Pharma International's Current Ratio distribution charts can be found below:

* The bar in red indicates where Hyphens Pharma International's Current Ratio falls into.



Hyphens Pharma International Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Hyphens Pharma International's Current Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Current Ratio (A: Dec. 2022 )=Total Current Assets (A: Dec. 2022 )/Total Current Liabilities (A: Dec. 2022 )
=89.652/40.074
=2.24

Hyphens Pharma International's Current Ratio for the quarter that ended in Jun. 2023 is calculated as

Current Ratio (Q: Jun. 2023 )=Total Current Assets (Q: Jun. 2023 )/Total Current Liabilities (Q: Jun. 2023 )
=91.151/41.486
=2.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hyphens Pharma International  (SGX:1J5) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Hyphens Pharma International Current Ratio Related Terms

Thank you for viewing the detailed overview of Hyphens Pharma International's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyphens Pharma International (SGX:1J5) Business Description

Traded in Other Exchanges
N/A
Address
16 Tai Seng Street, Level 4, Singapore, SGP, 534138
Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include Specialty Pharma Principals segment; Proprietary Brands segment and Medical Hypermart and Digital segment. Specialty pharma principals segment engages in the business of selling and marketing specialty pharmaceutical products. Proprietary Brands segment develops, markets and sells own proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore. Medical Hypermart and Digital is engaged in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan.

Hyphens Pharma International (SGX:1J5) Headlines

No Headlines